Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xeris Pharmaceuticals Inc

4.11
+0.03000.74%
Post-market: 4.10-0.0099-0.24%18:02 EDT
Volume:1.91M
Turnover:7.86M
Market Cap:632.69M
PE:-11.00
High:4.20
Open:4.08
Low:4.04
Close:4.08
Loading ...

BRIEF-Xeris Announces Changes To Its Board Of Directors

Reuters
·
28 Mar

Xeris Announces Changes to Its Board of Directors

THOMSON REUTERS
·
28 Mar

Is Xeris Biopharma Holdings (XERS) The Hot Biotech Stock Under $5?

Insider Monkey
·
27 Mar

Don't Ignore The Insider Selling In Xeris Biopharma Holdings

Simply Wall St.
·
23 Mar

Strength Seen in Xeris Biopharma (XERS): Can Its 5.6% Jump Turn into More Strength?

Zacks
·
20 Mar

Xeris Biopharma Says US FDA Approves Gvoke VialDx for Diagnostic Use

MT Newswires Live
·
17 Mar

Xeris Biopharma Holdings Inc - Gvoke Vialdx Expected to Be Available in Q3 2025

THOMSON REUTERS
·
17 Mar

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid

Business Wire
·
17 Mar

Xeris Biopharma Is Maintained at Buy by Craig-Hallum

Dow Jones
·
10 Mar

Xeris Biopharma price target raised to $6 from $5 at Leerink

TIPRANKS
·
08 Mar

Stock Track | Xeris Pharmaceuticals Soars 5.33% as Analysts Raise Price Targets

Stock Track
·
07 Mar

Xeris Biopharma price target raised to $4 from $3 at Piper Sandler

TIPRANKS
·
07 Mar

Xeris Biopharma Price Target Raised to $8.00/Share From $6.60 by HC Wainwright & Co.

Dow Jones
·
07 Mar

Xeris Biopharma price target raised to $8 from $6.60 at H.C. Wainwright

TIPRANKS
·
07 Mar

Xeris Biopharma Holdings Inc (XERS) Q4 2024 Earnings Call Highlights: Surpassing Revenue ...

GuruFocus.com
·
07 Mar

Xeris Biopharma files $250M mixed securities shelf

TIPRANKS
·
07 Mar

Xeris Biopharma Shares Rise on Expectation of Significant Full-Year Revenue Growth

Dow Jones
·
07 Mar

Stock Track | Xeris Pharmaceuticals Soars 9.81% on Record Q4 Results and Strong 2025 Outlook

Stock Track
·
06 Mar

Xeris Biopharma Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Mar

Here's What Key Metrics Tell Us About Xeris Biopharma (XERS) Q4 Earnings

Zacks
·
06 Mar